Who was studied, and how
Two numbers in the abstract
Where each one falls
Where it lands on the map
6,000people in the Effectiveness and Persistence of Therapy With GLP-1 Receptor Agonists in Clinical Practice. A Multicenter Retrospective Study trial, from 2018
of them with hypertension, in this paper
The trial randomly assignedassigned by chance
GLP-1 RAs
insulin
Reported lower long-term blood sugar, no range given−0.12
randomisedThe trial randomly assignedassigned by chance
basal insulin
GLP-1 RAs
Reported lower fasting blood sugar, no range given−1.80
randomisedthe abstract, start to end
… in reducing fasting plasma glucose (Δ -1.8 mmol/L, P < .0001).
← favours treatmentfavours comparator →
could be chanceNo interval given · direction only, strength unknown
HbA1cGLP-1 RAs vs insulin
−0.12
Fasting plasma glucosebasal insulin vs GLP-1 RAs
−1.8
GLP-1 receptor agonistsInsulinGlycemic control
1 / 4